Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees

Abstract excerpt

To the Editor—The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in places where the virus is uncontained poses a global threat from the perspective of public health and vaccine efficacy. Peng et al [1] recently reported on the increased transmissibility with the newly emerged Variant of Concern (VOC) (20C/S:452R and 20C/S:452R) with the L452R mutation in San Francisco. We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immunodeficiency and Autoimmune Disorders
• Share to SARS-CoV-2 and COVID-19 Research
• Share to Viral Infections and Immunology Research